Nucleix raised €47M in a funding round in Apr 2021. The company is based in Rehovot, Israel. Investors in the round: RA Capital Management. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
